Artiva Biotherapeutics Ratios (2023-2026) | ARTV

Ratios Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) -323.56%42.13%-493.66%-5,514.74%
EBIT Margin (Quarter) -338.12%40.56%-509.36%-5,773.71%
EBITDA Margin (Quarter) -338.12%40.56%-509.36%-5,773.71%
Operating Margin (Quarter) -338.12%40.56%-509.36%-5,773.71%
Net Margin (Quarter) -323.56%42.13%-493.66%-5,514.74%
FCF Margin (Quarter) -50.39%-336.77%-6,015.54%
Efficiency
Assets Average (Quarter) 150.75M217.59M200.42M180.33M159.13M139.90M118.45M
Asset Utilization Ratio (Quarter) 0.020.00
Leverage & Solvency
Interest Coverage Ratio (Quarter) -55.93-1.29-1.06-2.57-1.34-1.47-12.45-53.23-2.09
Times Interest Earned (Quarter) -55.93-1.29-1.06-2.57-1.34-1.47-12.45-53.23-2.09
Valuation
Enterprise Value (Quarter) -53.70M-65.89M19.80M-48.20M73.10M-146.63M-185.43M-165.96M-142.37M-220.46M-108.01M-152.63M
Return Ratios
Return on Sales (Quarter) -0.03%0.00%-0.05%-0.55%-0.01%-0.34%-3.94%
Return on Capital Employed (Quarter) -44.37%-32.77%-39.83%-48.11%-58.20%-70.82%-85.59%
Return on Assets (Quarter) -0.01%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%